Literature DB >> 10678339

The impact of regular vaginal pH screening on the diagnosis of bacterial vaginosis in pregnancy.

D Gjerdingen1, P Fontaine, M Bixby, J Santilli, J Welsh.   

Abstract

BACKGROUND: Bacterial vaginosis has recently been associated with preterm labor and delivery. The purpose of our study was to determine whether regular prenatal vaginal pH testing resulted in more frequent diagnoses of bacterial vaginosis and other vaginal infections, more frequent treatment with antibiotics, and fewer preterm deliveries. We also sought to determine the sensitivity and specificity of pH testing and vaginal symptom reporting in identifying vaginal infections.
METHODS: Our study was a prospective clinical trial involving 121 pregnant women randomized to receive either standard prenatal care, including routine inquiry about vaginal symptoms, or standard care supplemented by vaginal pH testing. Women with symptoms or a vaginal pH level >4.5 received a wet mount examination. Confirmed infections were treated according to study protocols.
RESULTS: Women who received regular pH testing showed significantly higher detection rates for bacterial vaginosis than controls (48.4% vs 27.1%, P =.015) and more frequent detection of Trichomonas vaginalis (7.8% vs 1.7%, P = .116). A higher percentage of women in the experimental group were treated for bacterial vaginosis and trichomoniasis (46.9% vs 27.1%, P =.024), and the preterm birth rate was one half that of the control group (4.7% vs 10.2%, P = .243). The presence of vaginal symptoms or a vaginal pH level >4.5 identified bacterial vaginosis or trichomoniasis with 84.4% sensitivity.
CONCLUSIONS: In our study, frequent vaginal pH testing during pregnancy resulted in more frequent diagnosis and treatment of bacterial vaginosis. Since vaginal symptoms and elevated pH levels appear to be useful in screening for bacterial vaginosis and trichomoniasis, frequent pH testing should be evaluated in larger studies.

Entities:  

Mesh:

Year:  2000        PMID: 10678339

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  6 in total

1.  Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth.

Authors:  Melissa S Mancuso; Dana Figueroa; Jeff M Szychowski; Merri Maddox Paden; John Owen
Journal:  Am J Obstet Gynecol       Date:  2010-12-22       Impact factor: 8.661

2.  Bacterial vaginosis during pregnancy. Should we screen for and treat it?

Authors:  Adrienne Einarson; Gideon Koren
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

3.  Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077].

Authors:  Christine L Roberts; Jonathan M Morris; Kristen R Rickard; Warwick B Giles; Judy M Simpson; George Kotsiou; Jennifer R Bowen
Journal:  BMC Pregnancy Childbirth       Date:  2011-03-11       Impact factor: 3.007

4.  A Protocol for the Multi-Omic Integration of Cervical Microbiota and Urine Metabolomics to Understand Human Papillomavirus (HPV)-Driven Dysbiosis.

Authors:  Nataliya Chorna; Filipa Godoy-Vitorino
Journal:  Biomedicines       Date:  2020-04-08

5.  Demonstration and Characterization of Cyst-Like Structures in the Life Cycle of Trichomonas vaginalis.

Authors:  Divya Beri; Priya Yadav; H R Nandini Devi; Chinmaya Narayana; Darshak Gadara; Utpal Tatu
Journal:  Front Cell Infect Microbiol       Date:  2020-01-14       Impact factor: 5.293

Review 6.  The Unique Microbiome and Innate Immunity During Pregnancy.

Authors:  Chunlei Mei; Weina Yang; Xin Wei; Kejia Wu; Donghui Huang
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.